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In recent years, epidemiological studies confirm the significant impact on human health by 
infections caused by pathogenic fungi. In fact, although the Candida genus is commensal and a 
constituent of the normal gut flora, it is responsible for opportunistic infections and can become 
pathogenic secondary to predisposing factors related to the host, like a comprimised immune system 
(AIDS, anti-cancer therapy, transplants), excessive prophylaxis with antimicrobial agents, and use 
of invasive catheters. Large-scale surveillance for fungal infections has demonstrated an increasing 
incidence of drug-resistant fungal pathogens. As a matter of fact, a significant number of fungi 
species (especially Candida glabrata and Candida krusei) exhibited primary resistance to 
Fluconazole or were less susceptible to Amphotericin B. 
Furthermore, as a consequence of the toxicity of the currently used polyene antifungal drugs, which 
leads to interrupt the therapy, and the emergence of Candida species resistance to azole-based 
agents, there is an urgent need for developing alternative drug therapies. 
In our previous study we have  disclosed the synthesis and antifungal activity of a series of 4-
nitrosopyrazoles that mainly displayed in vitro potent antifungal activity at no cytotoxic 
concentrations and that some of these compounds were 4 times more potent than Amphotericine B 
and Fluconazole respectively against Cryptococcus neoformans and Candida Krusei 
[1-4]
 
As part of our Structure Activity Relationships studies, we were interested in learning the influence 
of the steric and electronic effects of the substituent in position 5 of the 4-nitrosopyrazoles which 
had already showed powerful antimycotic activity. 







 R: a=H, b= CH3, c=C2H5 
Fig 1. Synthetized compounds 
The 5-carboxiethylester group has made the antimycotic actity dramatically decay, confirming the 
necessity, for a good antimicotic activity, of derivatives in which the position 5 is free or substituted 
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